Edgewise Therapeutics

Edgewise Therapeutics

Biotechnology Research

Boulder, CO 10,098 followers

On a mission to improve the lives of people facing serious muscle disease.

About us

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Boulder, CO
Type
Public Company
Founded
2017

Locations

Employees at Edgewise Therapeutics

Updates

Similar pages

Browse jobs

Funding

Edgewise Therapeutics 5 total rounds

Last Round

Post IPO equity

US$ 240.0M

See more info on crunchbase